ASHENEWS reports that renowned global biopharmaceutical company, AstraZeneca has announced plans to invest 1.5 billion dollars in building a manufacturing facility in Singapore for antibody-drug conjugates (ADCs).
Trending
- Physician highlights health implications of sleep deprivation
- Experts call for unified efforts to combat measles in Nigeria
- Over 40m people across West, Central Africa are struggling to feed — UN
- Niger Legislators confused over lack of defined roles for Humanitarian Ministry and NSEMA
- Explainer: Why children are more vulnerable to drowning
- Commissioner urged to address delays in road projects across Niger State
- Cyclone Chido death toll in Mozambique rises to 73
- Family of Late Emir of Borgu renew calls for justice over use of family land
